Every reporter Huang Bowen Every editor Yang Jun
As Dongfeng launched the "first shot" of the current round of price wars in Hubei, the preferential subsidies of major car companies and brands are also increasing. one".
According to media reports, more than 30 car companies have joined this round of "price wars" and launched "fancy" discounts one after another.
The price war itself is a double-edged sword for the brand. In many cases, it is "one thousand damage to the enemy and eight hundred damage to oneself".
On the one hand, lowering prices can certainly increase market share in the short term and suppress competitors; on the other hand, price wars can also cause confusion in product pricing and damage brand value to a certain extent.
What's more, more brands joining the battle will cause involution, which will greatly reduce the effect of price reduction.
The reporter of "Daily Economic News" found that the direct reasons for the price reduction are: first, the implementation of the new "National VI B" standard is imminent, and the inventory of car companies is large, so they have to cut prices; Car sales are sluggish, driving consumption.
The bigger background is the rise of new energy vehicles, which has caused a huge market squeeze on fuel vehicles.
New energy vehicles have started a price war, and fuel vehicles are even more difficult.
Therefore, it is certain that the auto industry is facing a drastic reshuffle, and the pain is unavoidable.
Strategic Decision
Vanke A (SZ000002): The fixed increase fundraising does not exceed 15 billion yuan, aiming to form a good asset-debt structure
On the evening of March 8, Vanke announced that the company's proposal for non-public issuance of A shares was reviewed and approved by the first extraordinary general meeting of shareholders in 2023.
According to previous disclosures, the fixed increase involves a fundraising scale of no more than 15 billion yuan, and the number of issued shares does not exceed 1.1 billion shares, accounting for 9.46% of Vanke's total share capital. The raised funds will be used for the company's 11 real estate development projects and supplementary liquidity. funds.
Zhu Jiusheng, president of Vanke, said that Vanke’s current round of equity financing was not due to lack of money. The company had already obtained sufficient bond financing before. One of the important considerations for this additional issuance is to form a good asset-debt structure; at the same time, grasp the structural opportunities emerging in the industry And the favorable policy window period is also one of the important reasons.
major release
BYD (SZ002594): Became the only company with positive growth in the top ten domestic auto sales from January to February
On March 10, according to data from the China Association of Automobile Manufacturers, from January to February, the sales volume of the top ten domestic auto sales groups totaled 2.56 million vehicles, a year-on-year decrease of 24.8%.
Among the top ten companies in the domestic sales of domestically produced cars, compared with the previous year, BYD's sales growth has achieved positive growth, while other companies have declined to varying degrees.
Among the top ten new energy sales companies, BYD sold 345,000 vehicles, with the most significant sales and year-on-year growth rate.
Sany Heavy Industry (SH600031): If the market value exceeds one trillion yuan, each gold medal employee will receive 5 million yuan
Recently, in CCTV's "Dialogue" program, the current chairman of Sany Heavy Industry revealed to Wen Bo that the first batch of entrepreneurial employees were gold medal employees of Sany Heavy Industry. ten thousand yuan.
After reaching the goal of 100 billion yuan, Liang Wengen, the former chairman, said that after the market value of Sany Heavy Industry exceeds 1 trillion yuan, each gold medal employee will be given 5 million yuan.
Performance announcement
Ningde Times (SZ300750): In 2022, revenue will increase by 152% year-on-year
On March 9, the financial report released by Ningde Times showed that the company will achieve operating income of 328.594 billion yuan in 2022, a year-on-year increase of 152.07%; net profit of 30.73 billion yuan, a year-on-year increase of 92.89%.
During the reporting period, the company achieved a sales volume of 289GWh of lithium-ion batteries, a year-on-year increase of 116.6%, of which the sales volume of power battery systems was 242GWh, a year-on-year increase of 107.09%.
The company's R&D investment in 2022 will reach 15.510 billion yuan, a year-on-year increase of 101.66%.
The company plans to convert 10 shares into 8 shares and distribute cash dividends of 25.2 yuan (including tax), with a total cash dividend of 6.155 billion yuan.
JD Group-SW(HK09618): The annual revenue in 2022 will exceed 1 trillion yuan for the first time
On March 9, the financial report released by Jingdong Group showed that the company's annual revenue in 2022 will be 1.0462 trillion yuan, breaking through 1 trillion yuan for the first time, a year-on-year increase of 9.9%; net profit is 10.4 billion yuan, compared with a net loss of 3.6 billion yuan last year .
In addition, the board of directors has approved a cash dividend of $0.31 per common share, or $0.62 per American depositary share, for a total dividend of approximately $1 billion.
China Unicom (SH600050): The net profit attributable to the parent in 2022 will be 7.299 billion yuan, a year-on-year increase of 15.8%
On March 8, the annual report released by China Unicom showed that in 2022, the company achieved operating income of 354.944 billion yuan, an increase of 8.3% year-on-year; net profit attributable to the parent was 7.299 billion yuan, a year-on-year increase of 15.8%.
Liu Liehong, chairman of China Unicom, said at the performance briefing that day that the company will achieve four new highs in 2022: the revenue growth rate will hit a new high in nine years, the profit scale will hit a new high since its listing, and the EBITDA (earnings before interest, tax, depreciation and amortization) will hit a new high after listing. Since then, the proportion of industrial Internet revenue has reached a record high.
Operational measures
BYD (SZ002594): Passenger cars are on sale in the UK, and 4 pioneer stores will open in mid-March
On March 8, BYD's first passenger car BYD ATTO 3 was officially launched in the UK, with a starting price of 36,490 pounds (about 300,000 yuan).
The first four Pioneer stores in Birmingham, Manchester, Glasgow and Milton Keynes will open in mid-March.
Dongfeng Group (HK00489): 56 fuel and new energy models introduced subsidies, triggering price cuts
"Daily Economic News" reported that recently, 56 fuel and new energy models of the "Dongfeng Series" have introduced subsidies ranging from 4,000 yuan to 90,000 yuan, and only 120,000 yuan can win a Dongfeng Citroen C6. March 31.
The huge discounts made Dongfeng models explode, and other car companies and provinces couldn't sit still.
The wave of price cuts in the auto market is spreading across the country with Hubei as the center.
According to incomplete statistics, at least 30 auto brands have launched preferential policies recently, with a maximum discount of more than 100,000 yuan, among which the number of joint venture brands accounts for a large proportion.
Industry Expansion
Wuliangye (SZ000858): Proposed investment in the construction of Wuliangye Technology Research Center Project
On March 8, Wuliangye announced that the company plans to invest in the construction of the Wuliangye Technology Research Center project, with an estimated total investment of about 480 million yuan. The investment amount was adjusted from 2.75 billion yuan to 2.358 billion yuan.
Pinduoduo (PDD): Cross-border e-commerce platform TEMU is expanding into the Australian market
According to recent media reports, Pinduoduo's cross-border e-commerce platform TEMU will officially enter Australia and New Zealand on March 13, continuing to promote the direct connection of Chinese manufacturing to Australia and the global market.
In September last year, Pinduoduo officially launched the cross-border e-commerce platform TEMU in North America.
Since its launch, TEMU has achieved full coverage of domestic manufacturing categories.
New product launch
Baidu Group - SW(HK09888): Plan to hold Baidu Wenxin Yiyan press conference at 14:00 on March 16
On March 10, according to Baidu's official news, Baidu plans to hold a press conference at the Beijing headquarters at 14:00 on March 16, with the theme centering on Wen Xin Yi Yan.
Baidu founder, chairman and CEO Robin Li, Baidu CTO Wang Haifeng will attend.
technological innovation
PetroChina (SH601857): 9396 meters!
Asia's deepest horizontal well drilled in Tarim Oilfield
On March 9, PetroChina’s Guole 3C well in the Fuman Oilfield in the hinterland of the Taklamakan Desert was successfully drilled, breaking the record for the deepest horizontal well in Asia with a well depth of 9,396 meters, marking that the ultra-deep oil and gas drilling capacity of the Tarim Oilfield has officially entered the 9,000-meter level It is a new stage and has the conditions to march to a depth of 10,000 meters.
personnel changes
China Unicom (SH600050): Appoint Cao Xingxin as senior vice president of the company
On March 8, China Unicom announced that the company's board of directors agreed to appoint Mr. Cao Xingxin as the company's senior vice president.
Sinopec (SH600028): Yu Xizhi resigned as vice president of the company
On March 9, Sinopec announced that Mr. Yu Xizhi resigned from the position of vice president of the company due to his age.
important cooperation
Shanghai Pharmaceuticals (SH601607): Signed a new drug combination development cooperation agreement with Kangfang Pharmaceuticals
On March 7, Shanghai Pharmaceuticals issued an announcement stating that the company signed the "New Drug Combination Development Cooperation Agreement" with Akeso Pharmaceuticals, agreeing that the two parties will jointly carry out joint drug development in China (including mainland China, Hong Kong, and Macau) The combination therapy of SPH4336 tablets and Kaitanil is used in the development of well-differentiated liposarcoma (WDLS)/dedifferentiated liposarcoma (DDLS) and other tumor indications, and promotes the research and development and production of combination products; IND or CTA applications, clinical phase Ib/IIa clinical trials, and subsequent phase III clinical trials that may be conducted by both parties.